SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anaïs Michaut, Caroline Moreau, Marie-Anne Robin, Bernard Fromenty, Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease, Liver International, 2014, 34, 7
  2. 2
    Mitchell R. McGill, Mengde Cao, Archie Svetlov, Matthew R. Sharpe, C. David Williams, Steven C. Curry, Anwar Farhood, Hartmut Jaeschke, Stanislav I. Svetlov, Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans, Biomarkers, 2014, 19, 3, 222

    CrossRef

  3. 3
    Rohit Singhal, Alison H Harrill, Francoise Menguy-Vacheron, Zaid Jayyosi, Hadj Benzerdjeb, Paul B Watkins, Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine, BMC Pharmacology and Toxicology, 2014, 15, 1, 42

    CrossRef

  4. 4
    Changchun Cai, Hai Huang, Sean Whelan, Li Liu, Benjamin Kautza, Jason Luciano, Guoliang Wang, Guoqiang Chen, Sladjana Stratimirovic, Allan Tsung, Timothy R. Billiar, Brian S. Zuckerbraun, Benzyl alcohol attenuates acetaminophen-induced acute liver injury in a Toll-like receptor-4-dependent pattern in mice, Hepatology, 2014, 60, 3
  5. 5
    Huailei Ma, Jing Ning, Xin Jin, Chunming Mao, Xiangli Bu, Miao Wang, Huan Liu, Kun Wang, Christopher Lausted, Leroy Hood, Jiankui Chen, Zhiyuan Hu, Betaine homocysteine methyltransferase (BHMT) as a specific and sensitive blood marker for acute liver injury, Biomarkers, 2014, 1

    CrossRef

  6. 6
    Akiko Eguchi, Alexander Wree, Ariel E. Feldstein, Biomarkers of liver cell death, Journal of Hepatology, 2014, 60, 5, 1063

    CrossRef

  7. You have free access to this content7
    James H. Lewis, Causality assessment: Which is best—expert opinion or RUCAM?, Clinical Liver Disease, 2014, 4, 1
  8. 8
    Tom Luedde, Neil Kaplowitz, Robert F. Schwabe, Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance, Gastroenterology, 2014, 147, 4, 765

    CrossRef

  9. 9
    Mitchell R. McGill, Feng Li, Matthew R. Sharpe, C. David Williams, Steven C. Curry, Xiaochao Ma, Hartmut Jaeschke, Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans, Archives of Toxicology, 2014, 88, 2, 391

    CrossRef

  10. 10
    Xi Yang, Zuquan Weng, Donna L. Mendrick, Qiang Shi, Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury, Toxicology Letters, 2014, 225, 3, 401

    CrossRef

  11. 11
    Anna-Karin M. Sjogren, Maria Liljevald, Björn Glinghammar, Johanna Sagemark, Xue-Qing Li, Anna Jonebring, Ian Cotgreave, Gabriella Brolén, Tommy B. Andersson, Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes, Archives of Toxicology, 2014, 88, 7, 1427

    CrossRef

  12. 12
    Walid M Chalhoub, Kayla D Sliman, Meera Arumuganathan, James H Lewis, Drug-induced liver injury: what was new in 2013?, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 7, 959

    CrossRef

  13. 13
    Merrie Mosedale, Hong Wu, C. Lisa Kurtz, Stephen P. Schmidt, Karissa Adkins, Alison H. Harrill, Dysregulation of protein degradation pathways may mediate the liver injury and phospholipidosis associated with a cationic amphiphilic antibiotic drug, Toxicology and Applied Pharmacology, 2014, 280, 1, 21

    CrossRef

  14. 14
    James W. Dear, Daniel J. Antoine, Philip Starkey-Lewis, Christopher E. Goldring, B. Kevin Park, Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis, British Journal of Clinical Pharmacology, 2014, 77, 5
  15. You have free access to this content15
    D. Nicholas Bateman, Robert Carroll, Janice Pettie, Takahiro Yamamoto, Muhammad E. M. O. Elamin, Lucy Peart, Margaret Dow, Judy Coyle, Kristina R. Cranfield, Christopher Hook, Euan A. Sandilands, Aravindan Veiraiah, David Webb, Alasdair Gray, Paul I. Dargan, David M. Wood, Simon H. L. Thomas, James W. Dear, Michael Eddleston, Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment, British Journal of Clinical Pharmacology, 2014, 78, 3
  16. 16
    Rui Kang, Ruochan Chen, Qiuhong Zhang, Wen Hou, Sha Wu, Lizhi Cao, Jin Huang, Yan Yu, Xue-gong Fan, Zhengwen Yan, Xiaofang Sun, Haichao Wang, Qingde Wang, Allan Tsung, Timothy R. Billiar, Herbert J. Zeh, Michael T. Lotze, Daolin Tang, HMGB1 in health and disease, Molecular Aspects of Medicine, 2014,

    CrossRef

  17. 17
    Petra Thulin, Gunnar Nordahl, Marcus Gry, Getnet Yimer, Eleni Aklillu, Eyasu Makonnen, Getachew Aderaye, Lars Lindquist, C. Mikael Mattsson, Björn Ekblom, Daniel J. Antoine, B. Kevin Park, Stig Linder, Alison H. Harrill, Paul B. Watkins, Björn Glinghammar, Ina Schuppe-Koistinen, Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts, Liver International, 2014, 34, 3
  18. 18
    Alison H. Harrill, John S. Eaddy, Kelly Rose, John M. Cullen, Lakshmi Ramanathan, Stephen Wanaski, Stephen Collins, Yu Ho, Paul B. Watkins, Edward L. LeCluyse, Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260, Toxicology and Applied Pharmacology, 2014, 277, 2, 131

    CrossRef

  19. 19
    Camilla Stephens, Raúl J. Andrade, M. Isabel Lucena, Mechanisms of drug-induced liver injury, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 4, 286

    CrossRef

  20. 20
    Mitchell R McGill, Hartmut Jaeschke, Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients, Expert Opinion on Drug Metabolism & Toxicology, 2014, 1

    CrossRef

  21. 21
    Perry H. Dubin, Hejun Yuan, Robert K. Devine, Linda S. Hynan, Mamta K. Jain, William M. Lee, Micro-RNA-122 levels in acute liver failure and chronic hepatitis C, Journal of Medical Virology, 2014, 86, 9
  22. 22
    Robert James Hornby, Philip Starkey Lewis, James Dear, Chris Goldring, B Kevin Park, MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans, Expert Review of Clinical Pharmacology, 2014, 7, 3, 349

    CrossRef

  23. 23
    Katharina John, Johannes Hadem, Till Krech, Kristin Wahl, Michael P. Manns, Steven Dooley, Sandor Batkai, Thomas Thum, Klaus Schulze-Osthoff, Heike Bantel, MicroRNAs play a role in spontaneous recovery from acute liver failure, Hepatology, 2014, 60, 4
  24. 24
    Ben Lu, Ce Wang, Mao Wang, Wei Li, Fangping Chen, Kevin J Tracey, Haichao Wang, Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review, Expert Review of Clinical Immunology, 2014, 10, 6, 713

    CrossRef

  25. 25
    Robert J. Fontana, Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives, Gastroenterology, 2014, 146, 4, 914

    CrossRef

  26. 26
    Munir Pirmohamed, Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions, Annual Review of Genomics and Human Genetics, 2014, 15, 1, 349

    CrossRef

  27. 27
    Anna Alisi, Valerio Nobili, Sara Ceccarelli, Nadia Panera, Cristiano De Stefanis, Rita De Vito, Roberta Vitali, Giorgio Bedogni, Clara Balsano, Salvatore Cucchiara, Laura Stronati, Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease, Expert Review of Molecular Diagnostics, 2014, 14, 6, 763

    CrossRef

  28. 28
    Minjun Chen, Jürgen Borlak, Weida Tong, Predicting idiosyncratic drug-induced liver injury – some recent advances, Expert Review of Gastroenterology & Hepatology, 2014, 8, 7, 721

    CrossRef

  29. 29
    D Nicholas Bateman, James W Dear, H K Ruben Thanacoody, Simon H L Thomas, Michael Eddleston, Euan A Sandilands, Judy Coyle, Jamie G Cooper, Aryelly Rodriguez, Isabella Butcher, Steff C Lewis, A D Bastiaan Vliegenthart, Aravindan Veiraiah, David J Webb, Alasdair Gray, Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial, The Lancet, 2014, 383, 9918, 697

    CrossRef

  30. 30
    Adriaan D.B. Vliegenthart, Philip Starkey Lewis, Carl S. Tucker, Jorge Del Pozo, Sebastein Rider, Daniel J. Antoine, Valérie Dubost, Magdalena Westphal, Pierre Moulin, Matthew A. Bailey, Jonathan G. Moggs, Chris E. Goldring, B. Kevin Park, James W. Dear, Retro-Orbital Blood Acquisition Facilitates Circulating microRNA Measurement in Zebrafish with Paracetamol Hepatotoxicity, Zebrafish, 2014, 11, 3, 219

    CrossRef

  31. 31
    Zhihua Qiu, Yimin Dai, Roadmap of miR-122-related clinical application from bench to bedside, Expert Opinion on Investigational Drugs, 2014, 23, 3, 347

    CrossRef

  32. 32
    Daniel J. Antoine, Alison H. Harrill, Paul B. Watkins, B. Kevin Park, Safety biomarkers for drug-induced liver injury – current status and future perspectives, Toxicology Research, 2014, 3, 2, 75

    CrossRef

  33. 33
    Mitchell R. McGill, Vincent S. Staggs, Matthew R. Sharpe, William M. Lee, Hartmut Jaeschke, Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome, Hepatology, 2014, 60, 4
  34. 34
    James W Dear, Daniel J Antoine, Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges, Expert Review of Clinical Pharmacology, 2014, 7, 2, 181

    CrossRef

  35. 35
    Haichao Wang, Mary F Ward, Andrew E Sama, Targeting HMGB1 in the treatment of sepsis, Expert Opinion on Therapeutic Targets, 2014, 18, 3, 257

    CrossRef

  36. 36
    J-X Li, J-M Feng, Y Wang, X-H Li, X-X Chen, Y Su, Y-Y Shen, Y Chen, B Xiong, C-H Yang, J Ding, Z-H Miao, The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury, Cell Death and Disease, 2014, 5, 6, e1278

    CrossRef

  37. 37
    David Nicholas Bateman, James W Dear, H K Ruben Thanacoody, Simon H L Thomas, Michael Eddleston, Treatment of paracetamol overdose – Authors'reply, The Lancet, 2014, 383, 9926, 1383

    CrossRef

  38. 38
    Kevin Park, Daniel J Antoine, Munir Pirmohamed, Treatment of paracetamol overdose: room for improvement?, The Lancet, 2014, 383, 9918, 672

    CrossRef

  39. 39
    Christine Bernsmeier, Charalambos G. Antoniades, Julia Wendon, What’s new in acute liver failure?, Intensive Care Medicine, 2014, 40, 10, 1545

    CrossRef

  40. 40
    Jiri Aubrecht, Shelli J Schomaker, David E Amacher, Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury, Genome Medicine, 2013, 5, 9, 85

    CrossRef

  41. 41
    Benjamin L. Woolbright, Daniel J. Antoine, Rosalind E. Jenkins, Mary Lynn Bajt, B. Kevin Park, Hartmut Jaeschke, Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice, Toxicology and Applied Pharmacology, 2013, 273, 3, 524

    CrossRef

  42. 42
    Laura P James, Prit Gill, Pippa Simpson, Predicting risk in patients with acetaminophen overdose, Expert Review of Gastroenterology & Hepatology, 2013, 7, 6, 509

    CrossRef

  43. 43
    Munir Pirmohamed, Mechanisms of Adverse Drug Reactions,